Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Pediatr Infect Dis J

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    November 2018
  1. MADRID L, Maculuve SA, Vilajeliu A, Saez E, et al
    Maternal Carriage of Group B Streptococcus and Escherichia coli in a District Hospital in Mozambique.
    Pediatr Infect Dis J. 2018;37:1145-1153.
    PubMed     Text format     Abstract available


    October 2018
  2. SIGAUQUE B, Moiane B, Massora S, Pimenta F, et al
    Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Pediatr Infect Dis J. 2018;37:1054-1060.
    PubMed     Text format     Abstract available


  3. ADACHI K, Xu J, Ank B, Watts DH, et al
    Congenital Cytomegalovirus and HIV Perinatal Transmission.
    Pediatr Infect Dis J. 2018;37:1016-1021.
    PubMed     Text format     Abstract available


    September 2018
  4. BARTLETT AW, Mohamed TJ, Sudjaritruk T, Kurniati N, et al
    Disease- and Treatment-Related Morbidity in Adolescents With Perinatal HIV Infection in Asia.
    Pediatr Infect Dis J. 2018 Sep 29. doi: 10.1097/INF.0000000000002208.
    PubMed     Text format     Abstract available


  5. CHATPORNVORARUX S, Maleesatharn A, Rungmaitree S, Wittawatmongkol O, et al
    Delayed Seroreversion in HIV-Exposed Uninfected Infants.
    Pediatr Infect Dis J. 2018 Sep 19. doi: 10.1097/INF.0000000000002196.
    PubMed     Text format     Abstract available


  6. LE ROUX SM, Donald KA, Kroon M, Phillips TK, et al
    HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
    Pediatr Infect Dis J. 2018 Sep 18. doi: 10.1097/INF.0000000000002193.
    PubMed     Text format     Abstract available


  7. GAFAR F, Arifin H, Jurnalis YD, Yani FF, et al
    Antituberculosis Drug-Induced Liver Injury in Children: Incidence and Risk Factors During the Two-Month Intensive Phase of Therapy.
    Pediatr Infect Dis J. 2018 Sep 18. doi: 10.1097/INF.0000000000002192.
    PubMed     Text format     Abstract available


  8. ANUGULRUENGKITT S, Cressey TR, Suntarattiwong P, Ounchanum P, et al
    Nevirapine Concentrations During the First Month of Life And Maternal Efavirenz Washout in High Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis.
    Pediatr Infect Dis J. 2018 Sep 10. doi: 10.1097/INF.0000000000002195.
    PubMed     Text format     Abstract available


  9. FIDLER K, Foster C, Lim EJ, Patel A, et al
    Reactivity of Routine HIV Antibody Tests in Children with Perinatally-Acquired HIV-1 in England: Cross Sectional Analysis.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002143.
    PubMed     Text format     Abstract available


  10. AYIEKO J, Chamie G, Balzer L, Kwarisiima D, et al
    Mobile, Population-Wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002142.
    PubMed     Text format     Abstract available


  11. FARNAES L, Coufal N, Spector SA
    Vaccine Strain Varicella Infection in an Infant with Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002183.
    PubMed     Text format     Abstract available


    August 2018
  12. FRIGATI L, Bekker A, Stroebele S, Goussard P, et al
    Culture-Confirmed Tuberculosis in South African Infants Younger Than 3 Months of Age: Clinical Presentation and Management of Respiratory Complications.
    Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002163.
    PubMed     Text format     Abstract available


  13. TRAHAN MJ, Lamarre V, Metras ME, Kakkar F, et al
    Use of Triple Combination Antiretroviral Therapy With Raltegravir as Empiric HIV Therapy in the High-Risk HIV-Exposed Newborn.
    Pediatr Infect Dis J. 2018 Aug 27. doi: 10.1097/INF.0000000000002180.
    PubMed     Text format     Abstract available


  14. BLIGNAUT E, Rossouw TM, Becker PJ, Mavuso DS, et al
    Gingival Recession and Localized Aggressive Periodontitis Among HIV-Infected Children and Adolescents Receiving Antiretroviral Therapy.
    Pediatr Infect Dis J. 2018 Aug 9. doi: 10.1097/INF.0000000000002166.
    PubMed     Text format     Abstract available


  15. MBUTHIA JK, Kabera BM, Karuga R, Ivui G, et al
    A Cross-sectional Study to Compare Hepatitis B Immunity in HIV-infected and HIV-uninfected Kenyan Children After Primary Hepatitis B Immunization.
    Pediatr Infect Dis J. 2018;37:e214-e215.
    PubMed     Text format     Abstract available


    July 2018
  16. HOVIS IW, Namuyonga J, Kisitu GP, Ndagire E, et al
    Deceased Prevalence of Rheumatic Heart Disease Confirmed Among HIV Positive Youth.
    Pediatr Infect Dis J. 2018 Jul 31. doi: 10.1097/INF.0000000000002161.
    PubMed     Text format     Abstract available


  17. KOURTIS AP, Wiener J, Wang L, Fan B, et al
    Tenofovir Disoproxil Fumarate use during Pregnancy and Infant Bone Health: the Tenofovir in Pregnancy Pilot Study.
    Pediatr Infect Dis J. 2018 Jul 31. doi: 10.1097/INF.0000000000002152.
    PubMed     Text format     Abstract available


  18. PATTEN G, Schomaker M, Davies MA, Rabie H, et al
    What Should we do When HIV-Positive Children Fail First-Line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.
    Pediatr Infect Dis J. 2018 Jul 31. doi: 10.1097/INF.0000000000002156.
    PubMed     Text format     Abstract available


    June 2018
  19. SAID K, Hella J, Ruzegea M, Solanki R, et al
    Immunologic-Based Diagnosis of Latent Tuberculosis among Children Less Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania: Implications for Tuberculosis Infection Screening.
    Pediatr Infect Dis J. 2018 Jun 27. doi: 10.1097/INF.0000000000002131.
    PubMed     Text format     Abstract available


    May 2018
  20. NSANZIMANA S, McArdle F, Remera E, Mulindabigwi A, et al
    Viral Suppression in a Nationwide Sample of HIV-infected Children on Antiretroviral Therapy in Rwanda.
    Pediatr Infect Dis J. 2018 May 21. doi: 10.1097/INF.0000000000002101.
    PubMed     Text format     Abstract available


  21. INAGAKI K, Blackshear C, Hobbs CV
    Pneumocystis Infection in Children: National Trends and Characteristics in the United States, 1997-2012.
    Pediatr Infect Dis J. 2018 May 21. doi: 10.1097/INF.0000000000002119.
    PubMed     Text format     Abstract available


  22. HUIBERS MHW, Moons P, Maseko N, Gushu MB, et al
    Multiplex Real-Time PCR Detection of Intestinal Protozoa in HIV-Infected Children in Malawi, Enterocytozoon Bieneusi is Common and Associated with Gastrointestinal Complaints and May Delay BMI (Nutritional Status) Recovery.
    Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000001924.
    PubMed     Text format     Abstract available


  23. BUCK WC, Manjate N, Ventura J, Nhassengo C, et al
    Spinal Tuberculosis in Young Human Immunodeficiency Virus-Exposed Infants: Two Cases of Probable Congenital Transmission.
    Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000002118.
    PubMed     Text format     Abstract available


  24. YEGANEH N, Watts DH, Xu J, Kerin T, et al
    Infectious Morbidity, Mortality and Nutrition in HIV-Exposed, Uninfected, Formula Fed Infants: Results from the HPTN 040/PACTG 1043 Trial.
    Pediatr Infect Dis J. 2018 May 10. doi: 10.1097/INF.0000000000002082.
    PubMed     Text format     Abstract available


  25. RUISENOR-ESCUDERO H, Sikorskii A, Familiar-Lopez I, Persaud D, et al
    Neruodevelopmental Outcomes in Pre-School Children Living with HIV-1 Subtypes A and D in Uganda.
    Pediatr Infect Dis J. 2018 May 9. doi: 10.1097/INF.0000000000002097.
    PubMed     Text format     Abstract available


  26. GOODENOUGH CJ, Patel K, Van Dyke RB
    Is there a Higher Risk of Mother-to-Child Transmission of HIV Among Pregnant Women with Perinatal HIV Infection?
    Pediatr Infect Dis J. 2018 May 4. doi: 10.1097/INF.0000000000002084.
    PubMed     Text format     Abstract available


    March 2018
  27. CHI BH, Mutale W, Winston J, Phiri W, et al
    Infant HIV-Free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-Based Cohort Study from Rural Zambia.
    Pediatr Infect Dis J. 2018 Mar 27. doi: 10.1097/INF.0000000000001997.
    PubMed     Text format     Abstract available


  28. NJUGUNA IN, Wagner AD, Omondi VO, Otieno VA, et al
    Financial Incentives for Pediatric HIV Testing in Kenya.
    Pediatr Infect Dis J. 2018 Mar 24. doi: 10.1097/INF.0000000000002035.
    PubMed     Text format     Abstract available


  29. ADACHI K, Xu J, Ank B, Watts DH, et al
    Congenital CMV and HIV Perinatal Transmission.
    Pediatr Infect Dis J. 2018 Mar 9. doi: 10.1097/INF.0000000000001975.
    PubMed     Text format     Abstract available


  30. IROH TAM PY, Wiens MO, Kabakyenga J, Kiwanuka J, et al
    Pneumonia in HIV-Exposed and Infected Children and Association with Malnutrition.
    Pediatr Infect Dis J. 2018 Mar 2. doi: 10.1097/INF.0000000000001971.
    PubMed     Text format     Abstract available


  31. MAJEKODUNMI AO, Callard R, Klein N, Lewis J, et al
    Re: Recovery of CD4 T Cells in HIV/HCV Coinfected Children: Is it Really Impaired?
    Pediatr Infect Dis J. 2018;37:278-279.
    PubMed     Text format    


  32. FERNANDEZ MCPHEE C, Sainz T, Navarro ML
    Recovery of CD4 T Cells in HIV/HCV Coinfected Children: Is it Really Impaired?
    Pediatr Infect Dis J. 2018;37:278.
    PubMed     Text format    


    February 2018
  33. SHARMA TS, Somarriba G, Arheart KL, Neri D, et al
    Longitudinal Changes in Body Composition by Dual Energy X-Ray Absorptiometry Among Perinatally HIV-Infected and HIV-Uninfected Youth: Increased Risk of Adiposity Among HIV-Infected Female Youth.
    Pediatr Infect Dis J. 2018 Feb 22. doi: 10.1097/INF.0000000000001963.
    PubMed     Text format     Abstract available


  34. BASTIAANS DET, Geelen SPM, Visser EG, van der Flier M, et al
    Pharmacokinetics, Short Term Safety and Efficacy of the Approved Once-Daily Darunavir/r Dosing Regimen in HIV-Infected Children.
    Pediatr Infect Dis J. 2018 Feb 22. doi: 10.1097/INF.0000000000001964.
    PubMed     Text format     Abstract available


  35. CRANMER LM, Draper HR, Mandalakas AM, Kim S, et al
    High Incidence of Tuberculosis Infection in HIV-Exposed Children Exiting an Isoniazid Preventive Therapy Trial.
    Pediatr Infect Dis J. 2018 Feb 16. doi: 10.1097/INF.0000000000001946.
    PubMed     Text format     Abstract available


  36. GOMEZ LA, Crowell CS, Njuguna I, Cranmer LM, et al
    Improved Neurodevelopment Following Antiretroviral Therapy in HIV-Infected Children.
    Pediatr Infect Dis J. 2018 Feb 12. doi: 10.1097/INF.0000000000001942.
    PubMed     Text format     Abstract available


  37. JESSON J, Dahourou DL, Folquet MA, Malateste K, et al
    Malnutrition, Growth Response and Metabolic Changes Within the First 24 Months After ART Initiation in HIV-Infected Children Treated Before the Age of Two Years in West Africa.
    Pediatr Infect Dis J. 2018 Feb 3. doi: 10.1097/INF.0000000000001932.
    PubMed     Text format     Abstract available


  38. BESTE S, Essajee S, Siberry G, Hannaford A, et al
    Optimal Antiretroviral Prophylaxis in Infants at High Risk of Acquiring HIV: A Systematic Review.
    Pediatr Infect Dis J. 2018;37:169-175.
    PubMed     Text format     Abstract available


    January 2018
  39. MAKADZANGE AT, Dougherty L, Birri R, Kupakuwana G, et al
    Temporal Improvements in Long-Term Outcome in Care Among HIV Infected Children Enrolled in Public ART Care: An Analysis of Outcomes From 2004-2012 in Zimbabwe.
    Pediatr Infect Dis J. 2018 Jan 18. doi: 10.1097/INF.0000000000001903.
    PubMed     Text format     Abstract available


  40. AURPIBUL L, Kariminia A, Vibol U, Fong MS, et al
    Seroprevalence of Hepatitis B among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
    Pediatr Infect Dis J. 2018 Jan 15. doi: 10.1097/INF.0000000000001901.
    PubMed     Text format     Abstract available


  41. SETH A, Malhotra RK, Gupta R, Chandra J, et al
    Effect of Antiretroviral Therapy on Growth Parameters of Children With HIV Infection.
    Pediatr Infect Dis J. 2018;37:85-89.
    PubMed     Text format     Abstract available


    December 2017
  42. CHARAN J, Goyal JP, Reljic T, Emmanuel P, et al
    Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis.
    Pediatr Infect Dis J. 2017 Dec 26. doi: 10.1097/INF.0000000000001879.
    PubMed     Text format     Abstract available


  43. RICE ML, Russell JS, Frederick T, Purswani M, et al
    Risk for Speech and Language Impairments in Pre-school Aged HIV-Exposed Uninfected Children with in utero Combination Antiretroviral Exposure.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001875.
    PubMed     Text format     Abstract available


  44. BROPHY J, Bitnun A, Alimenti A, Lapointe N, et al
    Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living with HIV.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001874.
    PubMed     Text format     Abstract available


  45. BELARD S, Heuvelings CC, Banderker E, Bateman L, et al
    Utility of Point-of-Care Ultrasound in Children with Pulmonary Tuberculosis.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001872.
    PubMed     Text format     Abstract available


  46. BAKER AN, Bayer AM, Viani RM, Kolevic L, et al
    Morbidity and Mortality of a Cohort of Peruvian HIV-Infected Children 2003-2012.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001865.
    PubMed     Text format     Abstract available


  47. BUCEK A, Leu CS, Benson S, Warne P, et al
    Psychiatric Disorders, Antiretroviral Medication Adherence, and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001866.
    PubMed     Text format     Abstract available


  48. ARCHARY M, Mcllleron H, Bobat R, La Russa P, et al
    Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV Infected Children and the Effect on Treatment Outcomes.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001867.
    PubMed     Text format     Abstract available


  49. SEVINSKY H, Zaru L, Wang R, Xu X, et al
    Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
    Pediatr Infect Dis J. 2017 Dec 4. doi: 10.1097/INF.0000000000001855.
    PubMed     Text format     Abstract available


  50. COTTON MF, Liberty A, Torres-Escobar I, Gonzalez-Tome MI, et al
    Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children Aged From 3 Months to <11 Years: the PRINCE-2 Study.
    Pediatr Infect Dis J. 2017 Dec 4. doi: 10.1097/INF.0000000000001856.
    PubMed     Text format     Abstract available


  51. DEHORITY W, Viani RM, Araneta MRG, Lopez G, et al
    Comparison of the QuantiFERON TB Gold In-tube Assay With Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection Among HIV-infected and Uninfected Children.
    Pediatr Infect Dis J. 2017;36:e317-e321.
    PubMed     Text format     Abstract available


  52. PAUL R, Prasitsuebsai W, Jahanashad N, Puthanakit T, et al
    Structural Neuroimaging and Neuropsychologic Signatures of Vertically Acquired HIV.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001852.
    PubMed     Text format     Abstract available


  53. SIBERRY GK
    Beyond Prevention of Vertical HIV Transmission - Improving Outcomes of HIV-Uninfected Infants Born to Mothers with HIV Infection.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001854.
    PubMed     Text format    


    November 2017
  54. PADMAPRIYADARSINI C, Shet A, Srinivasan R, Ramachandran G, et al
    High Prevalence of Lipid Abnormalities and Insulin Resistance Among Antiretroviral Naive HIV-Infected Children in India.
    Pediatr Infect Dis J. 2017 Nov 20. doi: 10.1097/INF.0000000000001829.
    PubMed     Text format     Abstract available


  55. ANGELIDOU KN, Palumbo P, Lindsey J, Violary A, et al
    Defining Study Outcomes That Better Reflect Individual Response to Treatment.
    Pediatr Infect Dis J. 2017 Nov 17. doi: 10.1097/INF.0000000000001766.
    PubMed     Text format     Abstract available


  56. MOYO F, Mazanderani AH, Barron P, Bhardwaj S, et al
    Introduction of Routine HIV Birth Testing in the South African National Consolidated Guidelines.
    Pediatr Infect Dis J. 2017 Nov 15. doi: 10.1097/INF.0000000000001840.
    PubMed     Text format     Abstract available


  57. JINDAL AK, Bhattad S, Suri D, Singhal M, et al
    Moyamoya Syndrome in a Child with HIV-1 Infection.
    Pediatr Infect Dis J. 2017 Nov 15. doi: 10.1097/INF.0000000000001841.
    PubMed     Text format     Abstract available


  58. SUCCI RC, Krauss MR, Harris DR, Machado DM, et al
    Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001831.
    PubMed     Text format     Abstract available


  59. MANDALAKAS AM, Highsmith HY, Harris NM, Pawlicka A, et al
    T-SPOT.TB(R) Performance in Routine Pediatric Practice in a Low TB Burden Setting.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001792.
    PubMed     Text format     Abstract available


  60. CORRIGAN B, Mukui I, Mulenga L, Mthethwa N, et al
    Characteristics of Treatment-Experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001843.
    PubMed     Text format     Abstract available


    October 2017
  61. PINTO JA, Capparelli EV, Warshaw M, Zimmer B, et al
    A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines.
    Pediatr Infect Dis J. 2017 Oct 28. doi: 10.1097/INF.0000000000001817.
    PubMed     Text format     Abstract available


  62. GIAQUINTO C, Mawela MP, Chokephaibulkit K, Negra MD, et al
    Pharmacokinetics, Safety, and Efficacy of Maraviroc in Treatment-Experienced Pediatric Patients Infected With CCR5-Tropic HIV-1.
    Pediatr Infect Dis J. 2017 Oct 7. doi: 10.1097/INF.0000000000001808.
    PubMed     Text format     Abstract available


  63. STANKIEVICH E, Malanca A, Foradori I, Ivalo S, et al
    Utility of Mobile Communication Devices as a Tool to Improve Adherence to Antiretroviral Treatment in HIV-Infected Children and Young Adults in Argentina.
    Pediatr Infect Dis J. 2017 Oct 7. doi: 10.1097/INF.0000000000001807.
    PubMed     Text format     Abstract available


  64. ROJAS SANCHEZ P, Dominguez S, Jimenez De Ory S, Prieto L, et al
    Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-Infected Pediatric Population in Madrid: 1993-2015 Analysis.
    Pediatr Infect Dis J. 2017 Oct 6. doi: 10.1097/INF.0000000000001760.
    PubMed     Text format     Abstract available


    September 2017
  65. ARYA BK, Bhattacharya SD, Sutcliffe CG, Ganaie F, et al
    Nasopharyngeal pneumococcal colonization and impact of a single dose of 13-valent pneumococcal conjugate vaccine in Indian children with HIV and their unvaccinated parents.
    Pediatr Infect Dis J. 2017 Sep 27. doi: 10.1097/INF.0000000000001800.
    PubMed     Text format     Abstract available


  66. SULIS G, Amadasi S, Odone A, Penazzato M, et al
    Antiretroviral Therapy in HIV Infected Children with Tuberculosis: A Systematic Review.
    Pediatr Infect Dis J. 2017 Sep 7. doi: 10.1097/INF.0000000000001784.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: